Fatty acyl CoA synthetase (FACS) is an enzyme that plays a key role in fatty acid metabolism. It is responsible for the activation of long-chain fatty acids by attaching them to coenzyme A (CoA) to form fatty acyl CoA, an essential step before the fatty acids can undergo further metabolic reactions.
FACS is found in various tissues, including the liver, adipose tissue, and muscle. It has a high affinity for long-chain fatty acids and is responsible for activating a wide range of fatty acids with different chain lengths and degrees of saturation.
The reaction catalyzed by FACS is an ATP-dependent process that involves the formation of an acyl adenylate intermediate, followed by the transfer of the activated fatty acid to CoA. The enzyme contains several domains, including an AMP-binding domain, a fatty acid-binding domain, and an acyl-CoA synthetase domain, which work together to catalyze the reaction.
FACS plays a vital role in energy metabolism, as it is a key enzyme in the process of fatty acid oxidation and energy production. Dysregulation of FACS has been linked to various metabolic disorders, including obesity, diabetes, and metabolic syndrome. Therefore, FACS inhibitors are considered potential targets for the development of new therapies for these diseases.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page